First Report of Salmonella enterica Serotype Paratyphi A Azithromycin Resistance Leading to Treatment Failure

被引：51
|
作者：
Molloy, Aoife [1 ]
Nair, Satheesh [3 ]
Cooke, Fiona J. [2 ]
Wain, John [3 ]
Farrington, Mark [2 ]
Lehner, Paul J. [1 ]
Torok, M. Estee [1 ]
机构：
[1] Addenbrookes Hosp, Dept Infect Dis, Cambridge, England
[2] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Hlth Protect Agcy, Cambridge, England
[3] Ctr Infect, Hlth Protect Agcy, Lab Gastrointestinal Pathogens, London, England
来源：
JOURNAL OF CLINICAL MICROBIOLOGY | 2010年 / 48卷 / 12期
基金：
英国医学研究理事会;
关键词：
TYPHOID-FEVER;
D O I：
10.1128/JCM.00648-10
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The prevalence of Salmonella enterica serotype Paratyphi A infection is increasing, and multidrug resistance is a well-recognized problem. Resistance to fluoroquinolones is common and leads to more frequent use of newer agents like azithromycin. We report the first case of azithromycin resistance and treatment failure in a patient with S. Paratyphi A infection.
引用
收藏
页码：4655 / 4657
页数：3
相关论文
共 50 条
  • [1] Case report: failure under azithromycin treatment in a case of bacteremia due to Salmonella enterica Paratyphi A
    Kobayashi, Tetsuro
    Hayakawa, Kayoko
    Mawatari, Momoko
    Mezaki, Kazuhisa
    Takeshita, Nozomi
    Kutsuna, Satoshi
    Fujiya, Yoshihiro
    Kanagawa, Shuzo
    Ohmagari, Norio
    Kato, Yasuyuki
    Morita, Masatomo
    [J]. BMC INFECTIOUS DISEASES, 2014, 14
  • [2] Case report: failure under azithromycin treatment in a case of bacteremia due to Salmonella enterica Paratyphi A
    Tetsuro Kobayashi
    Kayoko Hayakawa
    Momoko Mawatari
    Kazuhisa Mezaki
    Nozomi Takeshita
    Satoshi Kutsuna
    Yoshihiro Fujiya
    Shuzo Kanagawa
    Norio Ohmagari
    Yasuyuki Kato
    Masatomo Morita
    [J]. BMC Infectious Diseases, 14
  • [3] Failure of oral antibiotic therapy, including azithromycin, in the treatment of a recurrent breast abscess caused by Salmonella enterica serotype Paratyphi A
    Fernando, Shelanah
    Molland, Janice Gail
    Gottlieb, Thomas
    [J]. PATHOGENS AND GLOBAL HEALTH, 2012, 106 (06) : 366 - 369
  • [4] Azithromycin Resistance in Clinical Isolates of Salmonella enterica Serovars Typhi and Paratyphi in Bangladesh
    Ahsan, Sunjukta
    Rahman, Sahida
    [J]. MICROBIAL DRUG RESISTANCE, 2019, 25 (01) : 8 - 13
  • [5] Isolated high-level ciprofloxacin resistance in Salmonella enterica subsp enterica serotype Paratyphi A
    Harish, BN
    Madhulika, U
    Parija, SC
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2004, 53 (08) : 819 - 819
  • [6] Paratyphoid fever due to Salmonella enterica serotype Paratyphi A
    Kapil, A
    Sood, S
    Reddaiah, VP
    Das, B
    Seth, P
    [J]. EMERGING INFECTIOUS DISEASES, 1997, 3 (03) : 407 - 407
  • [7] Ciprofloxacin resistance in Salmonella enterica serotype Typhi/Paratyphi and antimicrobial agent quality and bioavailability
    Arya, Subhash C.
    Agarwal, Nirmala
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2006, 55 (07) : 965 - 965
  • [8] Ciprofloxacin treatment failure in a case of typhoid fever caused by Salmonella enterica serotype Paratyphi A with reduced susceptibility to ciprofloxacin
    Dimitrov, Tzonyo
    Udo, Edet E.
    Albaksami, Osama
    Kilani, Abdul A.
    Shehab, El-Din M. R.
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2007, 56 (02) : 277 - 279
  • [9] Azithromycin/ceftriaxoneBacterial resistance leading to treatment failure: case report
    [J]. Reactions Weekly, 2022, 1915 (1) : 93 - 93
  • [10] Drug-resistant Salmonella enterica serotype Paratyphi A in India
    Chandel, DS
    Chaudhry, R
    Dhawan, B
    Pandey, A
    Dey, AB
    [J]. EMERGING INFECTIOUS DISEASES, 2000, 6 (04) : 420 - 421
12345